CREDITRISKMONITOR COM INC, 10-Q filed on 12 Aug 21
v3.21.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2021
Aug. 12, 2021
Cover page.    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2021  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q2  
Document Transition Report false  
Entity File Number 1-8601  
Entity Registrant Name CreditRiskMonitor.com, Inc.  
Entity Central Index Key 0000315958  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 36-2972588  
Entity Address, Address Line One 704 Executive Boulevard  
Entity Address, Address Line Two Suite A  
Entity Address, City or Town Valley Cottage  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10989  
City Area Code 845  
Local Phone Number 230-3000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,722,401
v3.21.2
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 10,903,794 $ 10,302,732
Available-for-sale securities - municipal bonds 0 458,237
Accounts receivable, net of allowance of $30,000 2,945,382 2,557,443
Other current assets 804,329 589,072
Total current assets 14,653,505 13,907,484
Property and equipment, net 597,393 545,675
Operating lease right-to-use asset 2,106,977 2,200,031
Goodwill 1,954,460 1,954,460
Other assets 41,611 84,892
Total assets 19,353,946 18,692,542
Current liabilities:    
Unexpired subscription revenue 9,972,001 9,646,407
Accounts payable 181,914 130,089
Current portion of operating lease liability 169,516 161,874
Current portion of bank loan 1,561,500 1,299,007
Accrued expenses 1,687,076 1,822,485
Total current liabilities 13,572,007 13,059,862
Deferred taxes on income, net 332,897 333,432
Unexpired subscription revenue, less current portion 159,066 197,545
Bank loan, less current portion 0 262,493
Operating lease liability, less current portion 2,051,513 2,137,559
Total liabilities 16,115,483 15,990,891
Stockholders' equity:    
Preferred stock, $.01 par value; authorized 5,000,000 shares; none issued 0 0
Common stock, $.01 par value; authorized 32,500,000 shares; issued and outstanding 10,722,401 shares 107,224 107,224
Additional paid-in capital 29,786,923 29,760,533
Accumulated deficit (26,655,684) (27,166,106)
Total stockholders' equity 3,238,463 2,701,651
Total liabilities and stockholders' equity $ 19,353,946 $ 18,692,542
v3.21.2
CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Accounts receivable, allowance $ 30,000 $ 30,000
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 5,000,000 5,000,000
Preferred stock, issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 32,500,000 32,500,000
Common stock, issued (in shares) 10,722,401 10,722,401
Common stock, outstanding (in shares) 10,722,401 10,722,401
v3.21.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
CONDENSED STATEMENTS OF OPERATIONS [Abstract]        
Operating revenues $ 4,248,179 $ 3,852,003 $ 8,381,081 $ 7,560,754
Operating expenses:        
Data and product costs 1,573,686 1,515,469 3,201,472 3,041,797
Selling, general and administrative expenses 2,190,382 2,394,266 4,391,174 4,809,524
Depreciation and amortization 66,503 53,693 131,016 107,805
Total operating expenses 3,830,571 3,963,428 7,723,662 7,959,126
Income (loss) from operations 417,608 (111,425) 657,419 (398,372)
Other income 246 3,417 3,494 26,101
Income (loss) before income taxes 417,854 (108,008) 660,913 (372,271)
(Provision for) benefit from income taxes (95,146) 136,929 (150,491) 202,844
Net income (loss) $ 322,708 $ 28,921 $ 510,422 $ (169,427)
Net income per share - Basic (in dollars per share) $ 0.03 $ 0.00 $ 0.05 $ (0.02)
Net income per share - Diluted (in dollars per share) $ 0.03 $ 0.00 $ 0.05 $ (0.02)
Weighted average number of common shares outstanding - Basic (in shares) 10,722,401 10,722,401 10,722,401 10,722,401
Weighted average number of common shares outstanding - Diluted (in shares) 10,792,744 10,722,401 10,779,726 10,722,401
v3.21.2
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 107,224 $ 29,705,673 $ (27,118,678) $ 2,694,219
Balance (in shares) at Dec. 31, 2019 10,722,401      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 0 0 (169,427) (169,427)
Stock-based compensation 0 30,456 0 30,456
Balance at Jun. 30, 2020 $ 107,224 29,736,129 (27,288,105) 2,555,248
Balance (in shares) at Jun. 30, 2020 10,722,401      
Balance at Mar. 31, 2020 $ 107,224 29,720,901 (27,317,026) 2,511,099
Balance (in shares) at Mar. 31, 2020 10,722,401      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 0 0 28,921 28,921
Stock-based compensation 0 15,228 0 15,228
Balance at Jun. 30, 2020 $ 107,224 29,736,129 (27,288,105) 2,555,248
Balance (in shares) at Jun. 30, 2020 10,722,401      
Balance at Dec. 31, 2020 $ 107,224 29,760,533 (27,166,106) $ 2,701,651
Balance (in shares) at Dec. 31, 2020 10,722,401     10,722,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 0 0 510,422 $ 510,422
Stock-based compensation 0 26,390 0 26,390
Balance at Jun. 30, 2021 $ 107,224 29,786,923 (26,655,684) $ 3,238,463
Balance (in shares) at Jun. 30, 2021 10,722,401     10,722,401
Balance at Mar. 31, 2021 $ 107,224 29,769,955 (26,978,392) $ 2,898,787
Balance (in shares) at Mar. 31, 2021 10,722,401      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 0 0 322,708 322,708
Stock-based compensation 0 16,968 0 16,968
Balance at Jun. 30, 2021 $ 107,224 $ 29,786,923 $ (26,655,684) $ 3,238,463
Balance (in shares) at Jun. 30, 2021 10,722,401     10,722,401
v3.21.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 510,422 $ (169,427)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Deferred income taxes (535) (203,657)
Depreciation and amortization 131,016 107,805
Operating lease right-to-use asset, net 14,652 18,434
Stock-based compensation 26,390 30,456
Changes in operating assets and liabilities:    
Accounts receivable (387,939) 17,895
Other current assets (215,261) (248,805)
Other assets 43,282 2,273
Unexpired subscription revenue 287,115 748,936
Accounts payable 51,826 (50,131)
Accrued expenses (135,409) (66,334)
Net cash provided by operating activities 325,559 187,445
Cash flows from investing activities:    
Sale of available-for-sale securities - municipal bonds 458,237 0
Purchase of property and equipment (182,734) (69,131)
Net cash provided by (used in) investing activities 275,503 (69,131)
Cash flows from financing activities:    
Proceeds from bank loan 0 1,561,500
Net cash provided by financing activities 0 1,561,500
Net increase in cash and cash equivalents 601,062 1,679,814
Cash and cash equivalents at beginning of period 10,302,732 8,275,836
Cash and cash equivalents at end of period $ 10,903,794 $ 9,955,650
v3.21.2
Basis of Presentation
6 Months Ended
Jun. 30, 2021
Basis of Presentation [Abstract]  
Basis of Presentation
(1) Basis of Presentation

The accompanying unaudited condensed financial statements of CreditRiskMonitor.com, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure required by generally accepted accounting principles (“GAAP”) in the United States for complete financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of management, the accompanying unaudited condensed financial statements reflect all material adjustments, including normal recurring accruals, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods presented, and have been prepared in a manner consistent with the audited financial statements for the fiscal year ended December 31, 2020.

The results of operations for the three months and six months ended June 30, 2021 and 2020 are not necessarily indicative of the results for an entire fiscal year.

The December 31, 2020 balance sheet has been derived from the audited financial statements at that date, but does not include all disclosures required by GAAP. These condensed financial statements should be read in conjunction with the audited financial statements and the footnotes for the fiscal year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K.
v3.21.2
Recently Issued Accounting Standards
6 Months Ended
Jun. 30, 2021
Recently Issued Accounting Standards [Abstract]  
Recently Issued Accounting Standards

(2) Recently Issued Accounting Standards



The Financial Accounting Standards Board (“FASB”) and the SEC have issued certain accounting pronouncements that will become effective in subsequent periods; however, management does not believe that any of those pronouncements would have significantly affected the Company’s financial accounting measurements or disclosures had they been in effect during the interim periods for which financial statements are included in this quarterly report. Management also believes those pronouncements will not have a significant effect on the Company’s future financial position or results of operations.
v3.21.2
Revenue Recognition
6 Months Ended
Jun. 30, 2021
Revenue Recognition [Abstract]  
Revenue Recognition
(3) Revenue Recognition

The Company applies FASB Accounting Standards Codification (“ASC”) 606, Revenue from Contract with Customers (“ASC 606”) to recognize revenue. ASC 606 requires an entity to apply the following five-step approach: (1) identify the contract(s) with a customer; (2) identify each performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation; and (5) recognize revenue when or as each performance obligation is satisfied. The Company’s primary source of revenue is subscription income which is recognized ratably over the subscription term.
v3.21.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2021
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
(4) Stock-Based Compensation

The Company applies ASC 718, Compensation-Stock Compensation (“ASC 718”) to account for stock-based compensation.

The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and six months ended June 30:
 
    
3 Months Ended
June 30,
   
6 Months Ended
June 30,
 
   
2021
   
2020
   
2021
   
2020
 
                         
Data and product costs
  $
5,393
    $
5,583
    $
9,245
    $
11,166
 
Selling, general and administrative expenses
   
11,575
     
9,645
     
17,145
     
19,290
 
                                 
    $
16,968
    $
15,228
    $
26,390
    $
30,456
 
v3.21.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2021
Fair Value Measurements [Abstract]  
Fair Value Measurements
(5) Fair Value Measurements

The Company’s cash, cash equivalents and available-for-sale securities are stated at fair value. The carrying value of accounts receivable, other current assets, bank loan and accounts payable approximates fair market value because of the short maturity of these financial instruments.

The Company’s cash equivalents are generally classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

All available-for-sale securities as of December 31, 2020 were municipal bonds. Investments in municipal bonds are valued using pricing models maximizing the use of observable inputs for similar securities. Municipal bonds are classified as Level 2 of the fair value hierarchy.

The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of June 30, 2021 and December 31, 2020, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.

   
June 30, 2021
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash and cash equivalents
 
$
10,903,794
   
$
-
   
$
-
   
$
10,903,794
 

   
December 31, 2020
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash and cash equivalents
 
$
10,302,732
   
$
-
   
$
-
   
$
10,302,732
 
                                 
Available-for-sale securities
 
$
-
   
$
458,237
   
$
-
   
$
458,237
 

There were proceeds of $458,237 from the sale of available-for-sale securities for the period ended June 30, 2021.
v3.21.2
Net Income (loss) per Share
6 Months Ended
Jun. 30, 2021
Net Income (loss) per Share [Abstract]  
Net Income (loss) per Share

(6) Net Income (loss) per Share

Basic net income (loss) per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options.

 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
 
2021
 
2020
 
2021
 
2020
 
                 
Weighted average number of common shares outstanding – basic
   
10,722,401
     
10,722,401
     
10,722,401
     
10,722,401
 
Potential shares exercisable under stock option plans
   
278,100
     
-
     
278,100
     
-
 
 LESS: Shares which could be repurchased under treasury stock method     (207,757 )     -
      (220,775 )     -
 
                                 
Weighted average number of common shares outstanding – diluted
   
10,792,744
     
10,722,401
     
10,779,726
     
10,722,401
 

For the three and six months ended June 30, 2021, the computation of diluted net income per share excludes the effects of the assumed exercise of 290,650 and 290,650 options, respectively, since their inclusion would be anti-dilutive as their exercise prices were above market value.

For the three months ended June 30, 2020, the computation of diluted net income per share excludes the effects of the assumed exercise of 451,750 options since their inclusion would be anti-dilutive as their exercise prices were above market value.

During the six months ended June 30, 2020 the Company recorded a net loss. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Because the Company has reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share, as the effect of utilizing the fully diluted share count would have reduced the net loss per share. Therefore, all outstanding stock options were excluded from the computation of diluted net loss per share because their effect was anti-dilutive for each of the periods presented.
v3.21.2
Related Parties
6 Months Ended
Jun. 30, 2021
Related Parties [Abstract]  
Related Parties
(7) Related Parties

In October 2020, the Company’s Board of Directors appointed Michael Flum to serve as President and Chief Operating Officer. Previously, he was serving as Senior Vice President and Chief Operating Officer effective October 2019 and had served as Vice President of Operations & Alternative Data since June 2018. Mr. Flum is the son of Jerome Flum, the Company’s Chief Executive Officer and Chairman of the Board of Directors, and the brother of Joshua Flum, a Director of the Company.
v3.21.2
COVID-19
6 Months Ended
Jun. 30, 2021
COVID-19 [Abstract]  
COVID-19
(8) COVID-19

On March 11, 2020, the World Health Organization declared the outbreak of Coronavirus Disease 2019 (“COVID-19” or “virus”) as a global pandemic. The extent to which COVID-19 impacts the Company’s results will depend on future developments, which are highly uncertain and cannot be predicted, including new information, COVID mutations and variants which may emerge, and the speed and effectiveness of vaccinations. The Company has been operating remotely without any significant disruption of operations. To date, the Company’s data providers have provided an uninterrupted stream of information, thus enabling the Company to deliver its product. The Company is actively monitoring the renewal rates of its current customers and those that subscribed after the outbreak.

In response to COVID-19, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted on March 27, 2020. The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain refundable employee retention credits. Additionally, the CARES Act contains relief for small businesses through several new temporary programs, one of which is the Paycheck Protection Program (“PPP”). The PPP is a loan designed to provide a direct incentive for small businesses to keep their workers on the payroll. The Small Business Administration (“SBA”) will forgive loans if all employees are kept on the payroll for eight weeks and the money is used for payroll, rent or utilities. The Company applied for a loan under this program and has received $1.56 million. The SBA provides a “safe harbor” for borrowers and has deemed certifications regarding the necessity of the loan to have been made in good faith for borrowers of less than $2 million. The PPP loan is scheduled to mature on April 15, 2022, has a 1.00% interest rate, may be prepaid at any time without penalty and is subject to the terms and conditions applicable to all loans made pursuant to the PPP as administered by the SBA under the CARES Act. The loan and accrued interest is forgivable after eight weeks so long as the Company uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels.  The “PPP” was amended on June 5, 2020 by the Paycheck Protection Program Flexibility Act, which stated that payments are deferred until the date on which the amount of forgiveness determined is remitted to the lender, with a maximum deferral of up to 16 months. The President signed the Consolidated Appropriations Act 2021 (the “CAA”) into law on December 27, 2020. The new COVID-19 legislation enhances and expands certain aspects of the CARES Act, most notably allowing borrowers to select their covered period to meet payroll and qualified expense requirements between 8 and 24 weeks.  In accordance with the requirements for forgiveness of the PPP loan under the CARES Act, the Company has used the entire proceeds from the PPP loan for eligible payroll, benefits, rent, utility costs, and maintained its employment levels. The lender of this loan started accepting applications for forgiveness during the first quarter of 2021, and the Company has applied for forgiveness by the deadline set forth by the lender. The current portion of this loan, including interest that is due within the next 12 months is $1,561,500. The Company is waiting on the review process to be completed by the lender and the SBA.
v3.21.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2021
Stock-Based Compensation [Abstract]  
Stock-based Compensation Expense for Stock Options
The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and six months ended June 30:
 
    
3 Months Ended
June 30,
   
6 Months Ended
June 30,
 
   
2021
   
2020
   
2021
   
2020
 
                         
Data and product costs
  $
5,393
    $
5,583
    $
9,245
    $
11,166
 
Selling, general and administrative expenses
   
11,575
     
9,645
     
17,145
     
19,290
 
                                 
    $
16,968
    $
15,228
    $
26,390
    $
30,456
 
v3.21.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2021
Fair Value Measurements [Abstract]  
Cash and Cash Equivalents Measured at Fair Value on Recurring Basis
The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of June 30, 2021 and December 31, 2020, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.

   
June 30, 2021
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash and cash equivalents
 
$
10,903,794
   
$
-
   
$
-
   
$
10,903,794
 

   
December 31, 2020
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash and cash equivalents
 
$
10,302,732
   
$
-
   
$
-
   
$
10,302,732
 
                                 
Available-for-sale securities
 
$
-
   
$
458,237
   
$
-
   
$
458,237
 
v3.21.2
Net Income (loss) per Share (Tables)
6 Months Ended
Jun. 30, 2021
Net Income (loss) per Share [Abstract]  
Computation of Basic and Diluted Net Income (Loss) per Share
Basic net income (loss) per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options.

 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
 
2021
 
2020
 
2021
 
2020
 
                 
Weighted average number of common shares outstanding – basic
   
10,722,401
     
10,722,401
     
10,722,401
     
10,722,401
 
Potential shares exercisable under stock option plans
   
278,100
     
-
     
278,100
     
-
 
 LESS: Shares which could be repurchased under treasury stock method     (207,757 )     -
      (220,775 )     -
 
                                 
Weighted average number of common shares outstanding – diluted
   
10,792,744
     
10,722,401
     
10,779,726
     
10,722,401
 
v3.21.2
Stock-Based Compensation (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Stock-based compensation expense for stock options [Abstract]        
Stock-based compensation expense $ 16,968 $ 15,228 $ 26,390 $ 30,456
Data and Product Costs [Member]        
Stock-based compensation expense for stock options [Abstract]        
Stock-based compensation expense 5,393 5,583 9,245 11,166
Selling, General and Administrative Expenses [Member]        
Stock-based compensation expense for stock options [Abstract]        
Stock-based compensation expense $ 11,575 $ 9,645 $ 17,145 $ 19,290
v3.21.2
Fair Value Measurements (Details) - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Cash and cash equivalents measured at fair value on recurring basis [Abstract]      
Proceeds from the sale of available-for-sale securities $ 458,237 $ 0  
Recurring [Member]      
Cash and cash equivalents measured at fair value on recurring basis [Abstract]      
Cash and cash equivalents 10,903,794   $ 10,302,732
Available-for-sale securities     458,237
Recurring [Member] | Level 1 [Member]      
Cash and cash equivalents measured at fair value on recurring basis [Abstract]      
Cash and cash equivalents 10,903,794   10,302,732
Available-for-sale securities     0
Recurring [Member] | Level 2 [Member]      
Cash and cash equivalents measured at fair value on recurring basis [Abstract]      
Cash and cash equivalents 0   0
Available-for-sale securities     458,237
Recurring [Member] | Level 3 [Member]      
Cash and cash equivalents measured at fair value on recurring basis [Abstract]      
Cash and cash equivalents $ 0   0
Available-for-sale securities     $ 0
v3.21.2
Net Income (loss) per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Net Income (loss) per Share [Abstract]        
Weighted average number of common shares outstanding - basic (in shares) 10,722,401 10,722,401 10,722,401 10,722,401
Potential shares exercisable under stock option plans (in shares) 278,100 0 278,100 0
LESS: Shares which could be repurchased under treasury stock method (in shares) (207,757) 0 (220,775) 0
Weighted average number of common shares outstanding - diluted (in shares) 10,792,744 10,722,401 10,779,726 10,722,401
Stock Options [Member]        
Antidilutive Securities Excluded from Computation [Abstract]        
Antidilutive securities excluded from computation of earnings per share (in shares) 290,650 451,750 290,650  
v3.21.2
COVID-19 (Details) - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Loans Payable [Abstract]    
Proceeds from loans $ 0 $ 1,561,500
PPP Loan [Member]    
Loans Payable [Abstract]    
Proceeds from loans $ 1,560,000  
Maturity date Apr. 15, 2022  
Interest rate 1.00%  
Current portion of loan including interest $ 1,561,500  
PPP Loan [Member] | Maximum [Member]    
Loans Payable [Abstract]    
Paycheck protection program deferral payments period 16 months